Search

Your search keyword '"Puthanakit, Thanyawee"' showing total 955 results

Search Constraints

Start Over You searched for: Author "Puthanakit, Thanyawee" Remove constraint Author: "Puthanakit, Thanyawee"
955 results on '"Puthanakit, Thanyawee"'

Search Results

1. Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study

5. Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium

6. Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms

7. Federated learning for predicting clinical outcomes in patients with COVID-19

8. Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines

11. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

12. Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational study

13. Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial

16. A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women

20. Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey

21. Mapping abnormal subcortical neurodevelopment in a cohort of Thai children with HIV

22. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

23. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

24. What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies

28. High mortality in adolescents and young adults with perinatally-acquired HIV in Thailand during the transition to adulthood

33. Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

34. High prescribing rates of third-generation cephalosporins in children hospitalized with acute lower respiratory infections at a university hospital

35. Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium

36. Severe Recurrent Bacterial Pneumonia Among Children Living With HIV

37. Integration of mental health services into HIV healthcare facilities among Thai adolescents and young adults living with HIV

38. Conference Proceedings From the 26th Bangkok International Symposium on HIV Medicine

39. Incidence of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 Pandemic

40. Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines

41. Opportunities for building lifelong resilience and improving mental health for adolescents living with HIV.

42. Effects of vitamin D and calcium supplementation on bone mineral density among Thai youth using daily HIV pre-exposure prophylaxis

43. Implementation of an active case management network to identify HIV-positive infants and accelerate the initiation of antiretroviral therapy, Thailand 2015 to 2018

44. Brain Imaging and Neurodevelopment in HIV-uninfected Thai Children Born to HIV-infected Mothers

45. Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in Asia

46. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries

47. Are we there yet? 40 years of successes and challenges for children and adolescents living with HIV

48. Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV

49. Association between lymphocyte and monocyte subsets and cognition in children with HIV.

50. Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

Catalog

Books, media, physical & digital resources